
"The industry has responded in an unprecedented way," said Thomas Cueni, Director General of The International Federation of Pharmaceutical Manufacturers & Associations in a virtual press conference held today. Despite it being only two and a half months since COVID-19 was declared a global pandemic, over 100 vaccine candidates are at various stages in the biopharmaceutical development pipeline.
TechnologyNetwork
No comments:
Post a Comment